BRIEF-Sinclair IS Pharma sees strong H2 delivering in-line results

Thu Jan 16, 2014 2:30am EST

Related Topics

Jan 16 (Reuters) - Sinclair IS Pharma PLC : * Revenues for H1 expected to be approximately £24.5 million (£23.0 million H1

FY 2013) * Strong H2 expected to produce c7% lfl growth

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.